Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PILOT-BTC: Paclitaxel Polymer Micelle Immunocombination in Advanced Biliary Tract Cancer
NCT07159204Phase 2Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in biliary tract cancer (BTC), sponsored by Peking Union Medical College Hospital. Primary endpoint: Objective Response Rate at 24 months. Started Aug 2024; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT07159204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07159204.